Dear customers,

we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.

RIDA®GENE Flu & SARS-CoV-2

Intended use:For in vitro diagnostic use. The RIDA®GENE Flu & SARS-CoV-2 test, performed on the LightCycler® 480II real-time PCR instrument, is a multiplex real-time RT-PCR for the direct [...]

RIDA®GENE SARS-CoV-2

Intended use:For in vitro diagnostic use. The RIDA®GENE SARS-CoV-2 test, which will be performed on the Roche LightCycler® 480II, is a multiplex real-time RT-PCR for the direct qualitative [...]

RIDA®GENE Enterovirus

Intended use:For in vitro diagnostic use. RIDA®GENE Enterovirus is a multiplex real-time RT-PCR for the direct qualitative detection of Enterovirus from human stool samples and cerebrospinal [...]

RIDA®GENE CAP Bac

Intended use:For in vitro diagnostic use. RIDA®GENE CAP Bac is a multiplex real-time PCR for the direct qualitative detection and differentiation of Chlamydophila pneumoniae (Chlamydia [...]

RIDA®GENE Gut Balance

Intended use:For in vitro diagnostic use. RIDA®GENE Gut Balance is a multiplex real-time PCR for the direct qualitative and quantitative detection of Bacteroides– and Cluster XIVa DNA from [...]

page  1  of  9